| Metric | Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue | 1.7B -12.0% | 1.9B +19.0% | 1.6B +1.9% | 1.6B +24.1% | 1.2B |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 1.7B -12.0% | 1.9B +19.0% | 1.6B +1.9% | 1.6B +24.1% | 1.2B |
| Operating Expenses | 1.2B -7.3% | 1.3B +7.6% | 1.2B +5.4% | 1.2B +28.9% | 912.0M |
| R&D | 0 | 0 | 0 | 0 | 0 |
| SG&A | 838.0M -7.6% | 907.0M +10.7% | 819.0M +3.3% | 793.0M +23.9% | 640.0M |
| Operating Income | 417.0M -23.6% | 546.0M +60.6% | 340.0M -9.1% | 374.0M +11.0% | 337.0M |
| EBITDA | 435.0M -22.7% | 563.0M +57.3% | 358.0M -7.7% | 388.0M +11.2% | 349.0M |
| Net Income | 289.0M -32.3% | 427.0M +59.3% | 268.0M +17.0% | 229.0M -2.1% | 234.0M |
| EPS (Basic) | $0.86 -32.3% | $1.27 +62.8% | $0.78 +14.7% | $0.68 -13.9% | $0.79 |
| EPS (Diluted) | $0.84 -20.8% | $1.06 +39.5% | $0.76 +11.8% | $0.68 -12.8% | $0.78 |
| Shares (Diluted) | 334.0M -0.9% | 337.0M -1.5% | 342.0M +3.0% | 332.0M +13.3% | 293.0M |